KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Goodwill (2016 - 2025)

Gilead Sciences (GILD) has disclosed Goodwill for 15 consecutive years, with $8.3 billion as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Goodwill changed 0.0% year-over-year to $8.3 billion, compared with a TTM value of $8.3 billion through Mar 2025, changed 0.0%, and an annual FY2024 reading of $8.3 billion, changed 0.0% over the prior year.
  • Goodwill was $8.3 billion for Q1 2025 at Gilead Sciences, roughly flat from $8.3 billion in the prior quarter.
  • Across five years, Goodwill topped out at $8.3 billion in Q1 2022 and bottomed at $8.3 billion in Q1 2022.
  • Average Goodwill over 4 years is $8.3 billion, with a median of $8.3 billion recorded in 2022.
  • Peak annual rise in Goodwill hit 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
  • Year by year, Goodwill stood at $8.3 billion in 2022, then changed by 0.0% to $8.3 billion in 2023, then changed by 0.0% to $8.3 billion in 2024, then changed by 0.0% to $8.3 billion in 2025.
  • Business Quant data shows Goodwill for GILD at $8.3 billion in Q1 2025, $8.3 billion in Q4 2024, and $8.3 billion in Q1 2024.